losartan has been researched along with fibrinogen in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Born, GV; Brown, MJ; Cardona-Sanclemente, LE; Medina, R | 1 |
Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
Shand, BI | 1 |
Beevers, DG; Li-Saw-Hee, FL; Lip, GY | 1 |
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
Hatzizacharias, A; Krespi, P; Makris, TK; Papadopoulos, DP; Stavroulakis, G; Tsoukala, C; Votteas, VE; Zilidis, A | 1 |
Baines, D; Isaacs, S; Opie, LH; Rayner, BL; Trinder, YA | 1 |
Huang, CH; Lai, WT; Lin, TH; Sheu, SH; Su, HM; Voon, WC; Yen, HW | 1 |
7 trial(s) available for losartan and fibrinogen
Article | Year |
---|---|
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril | 1998 |
Haemorheological effects of losartan and enalapril in patients with renal parenchymal disease and hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Circulation; Blood Viscosity; Enalapril; Erythrocyte Deformability; Female; Fibrinogen; Humans; Hypertension; Kidney Diseases; Losartan; Male; Middle Aged; Prospective Studies | 2000 |
Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Cross-Sectional Studies; Double-Blind Method; Enalapril; Female; Fibrinogen; Hemostasis; Humans; Hypertension; Losartan; Male; Middle Aged; P-Selectin; Pilot Projects; Plasminogen Inactivators; Prospective Studies; Statistics, Nonparametric; von Willebrand Factor | 2001 |
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1 | 2002 |
Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Drug Administration Schedule; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemostasis; Humans; Hypertension; Imidazoles; Lipoproteins; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Thiophenes; Thrombomodulin; Time Factors; Tissue Plasminogen Activator | 2004 |
Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diuretics; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Hyperuricemia; Losartan; Male; Tetrazoles; Treatment Outcome; Uric Acid | 2006 |
Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters.
Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2006 |
1 other study(ies) available for losartan and fibrinogen
Article | Year |
---|---|
Effect of captopril and losartan on blood pressure and accumulation of LDL and fibrinogen by aortic wall and other tissues in normotensive and hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Captopril; Fibrinogen; Hypertension; Imidazoles; Lipoproteins, LDL; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1997 |